Journal Information
Vol. 44. Issue S1.
Pages S21 (October 2022)
Share
Share
Download PDF
More article options
Vol. 44. Issue S1.
Pages S21 (October 2022)
CHRONIC LEUKEMIASPP16
Open Access
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA – CHALLENGING ISSUES OF HEMATO-ONCOLOGY
Visits
561
Vasile Musteata1, Larisa Musteata1, Dana Coman1
1 State University of Medicine and Pharmacy “N. Testemitanu”, Institute of Oncology
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 44. Issue S1
More info
Objective

Theaim of the study was to identify the diagnosis features and origin of the infectious complications in chronic lymphocytic leukemia (CLL).

Methodology

Our observational study enrolled 82 patients (pts) with different CLL phases, who were managed at the Institute of Oncology of Moldova from 2000 to 2022. The pts age ranged between 45-86 years (median age 66.2 years). There were 47 (57.3%) males and 35 (42.7%) females. The diagnosis was proved by histopathological, immunohistochemical, cytological and immunophenotyping examinations. We used IWCLL criteria on a basis of lymphoid cells rate in the blood count and bone marrow aspirate.

Results

Accordingto Binet classification, stage A was revealed in 54 (65.9%) pts, stage B – in 28 (34.1%). Infectious complications developed in 36 (43.9%) cases. Respiratory bacterial infections were diagnosed in 29 (80.6%) pts, commonly comprised the relapses of chronic bronchitis - in 11 (30.6%) and acute pneumonia - in 10 (27.8%). Herpetic infection was diagnosed in 2 (5.6%) cases. Other infectious complications included nephro-urinary tract in 3 (8.2%) pts and acute otitis in 2 (5.6%). Fatal outcomes occurred in 16 (19.5%) pts, including 6 (37.5%) with infections, 5 (31.3%) with CLL progression.

Conclusion

The infectious complications proved to be the common manifestations and causes of death in CLL, especially in stage B.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools